Long‐term efficacy of the hepatitis B Vaccine in a high‐risk group
- 12 July 2013
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 85 (9) , 1518-1522
Abstract
Chronic infection with hepatitis B virus (HBV) is a global health problem. In an attempt to control infection, worldwide HBV vaccination programs have been established. Saudi Arabia, an endemic area for HBV infection, established an HBV immunization program in 1989. This cross‐sectional study evaluates the long‐term protection of HBV vaccination 14–24 years after primary immunization in a high‐risk group (clinical year medical students) at King Abdulaziz University Hospital in Jeddah, Saudi Arabia. All participants had complete HBV immunization at birth or in early childhood. Hepatitis B surface antibody (anti‐HBs) levels were obtained. An anti‐HBs titer of 10 mIU/ml was considered to represent protective immune status. A total of 238 students were included; they were predominantly females (n = 182, 76.5%). Mean age was 22.2 ± 1.1 years. Duration since primary vaccination was 19.8 ± 2.3 years. Female students were more likely to maintain long‐term protection compared to males (62.1% and 58.8%, respectively). Anti‐HBs levels were significantly low in many students after primary immunization. Testing medical students for anti‐HBs levels may be warranted as they represent a high‐risk population. The higher rate of vaccine failure in males than females requires further investigation as it may explain the higher prevalence of HBV in the male population. J. Med. Virol. 85:1518–1522, 2013.Keywords
This publication has 38 references indexed in Scilit:
- Long-Term Persistence of Seroprotection by Hepatitis B Vaccination in Healthcare Workers of Southern ItalyHepatitis Monthly, 2012
- Epidemiology of viral hepatitis in Saudi Arabia: Are we off the hook?Saudi Journal of Gastroenterology, 2012
- Chronic hepatitis B: Update 2009 #Hepatology, 2009
- Survey of the level of anti‐HBs antibody titer in vaccinated Iranian general dentistsSpecial Care in Dentistry, 2008
- A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccinesBMC Infectious Diseases, 2008
- Hepatitis B vaccine boosters: Is there a clinical need in high endemicity populations?Journal of Gastroenterology and Hepatology, 2005
- Seroepidemiology of Hepatitis B virus infection in Saudi children 8 years after a mass hepatitis B vaccination programmeJournal of Infection, 1999
- Intramuscular versus Intradermal Administration of a Recombinant Hepatitis B Vaccine: A Comparison of Response Rates and Analysis of Factors Influencing the Antibody ResponseScandinavian Journal of Infectious Diseases, 1992
- Hepatitis B virus markers in a Saudi populationResearch in Virology, 1990
- Hepatitis B: global importance and need for controlVaccine, 1990